Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Research

• Publication date

  2010-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-09-4032PMID 20197472PMCID PMC3310185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers.

  2010cited by this paper
• Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification.

  2010cited by this paper
• Oncogenic role of miR-483-3p at the IGF2/483 locus.

  2010cited by this paper
• Tumor Site–Specific Silencing ofNF-κB p65by Targeted Hollow Gold Nanosphere–Mediated Photothermal Transfection

  2010cited by this paper
• The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.

  2010cited by this paper
• Integrin α4β1 Signaling Is Required for Lymphangiogenesis and Tumor Metastasis

  2010cited by this paper
• Molecular mechanism of chemoresistance by astrocyte elevated gene-1.

  2010cited by this paper
• Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.

  2010cited by this paper
• The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms.

  2010cited by this paper
• Coordination of centrosome homeostasis and DNA repair is intact in MCF-7 and disrupted in MDA-MB 231 breast cancer cells.

  2010cited by this paper
• ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.

  2010cited by this paper
• 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.

  2010cited by this paper
• Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells.

  2010cited by this paper
• Immunohistochemical expression of BRCA1 and lethal prostate cancer.

  2010cited by this paper
• Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.

  2010cited by this paper
• Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.

  2009cited by this paper
• Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor

  2009cited by this paper
• Motility Induction in Breast Carcinoma by Mammary Epithelial Laminin 332 (Laminin 5)

  2009cited by this paper
• The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin‐511

  2008cited by this paper
• Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.

  2008cited by this paper
• The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance

  2008cited by this paper
• Targeting of tetraspanin proteins — potential benefits and strategies

  2008cited by this paper
• Lapatinib Resistance in HCT116 Cells Is Mediated by Elevated MCL-1 Expression and Decreased BAK Activation and Not by ERBB Receptor Kinase Mutation

  2008cited by this paper
• CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.

  2008influential reference
• EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation

  2008cited by this paper
• Evidence for a role of tumor-derived laminin-511 in the metastatic progression of breast cancer.

  2007cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2007cited by this paper
• Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo

  2007cited by this paper
• Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro.

  2007cited by this paper
• Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma.

  2007cited by this paper
• alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary acini.

  2007cited by this paper
• Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulin-like growth factor I signaling

  2007cited by this paper
• α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini

  2007cited by this paper
• Integrin-mediated adhesion: tipping the balance between chemosensitivity and chemoresistance.

  2007cited by this paper
• HER2 therapy: Molecular mechanisms of trastuzumab resistance

  2006cited by this paper
• Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

  2006cited by this paper
• Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model

  2006cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Predictive value of laminin‐5 and membrane type 1‐matrix metalloproteinase expression for cervical lymph node metastasis in T1 and T2 squamous cell carcinomas of the tongue and floor of the mouth

  2006cited by this paper
• Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells

  2005cited by this paper
• Focal adhesion kinase: in command and control of cell motility

  2005cited by this paper
• Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

  2005cited by this paper
• ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors

  2005cited by this paper
• Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.

  2005cited by this paper
• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

  2004influential reference
• Laminin-5 offsets the efficacy of gefitinib (‘Iressa’) in hepatocellular carcinoma cells

  2004cited by this paper
• American Association for Cancer Research

  2004cited by this paper
• Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis

  2004cited by this paper
• Autocrine laminin-5 ligates 6 4 integrin and activates RAC and NF B to mediate anchorage-independent survival of mammary tumors

  2003cited by this paper
• Focal adhesion kinase: the first ten years

  2003cited by this paper
• Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain.

  2003influential reference
• Clinical significance of transmembrane 4 superfamily in colon cancer

  2003cited by this paper
• Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.

  2003cited by this paper
• beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.

  2002cited by this paper
• Distinct Functions For Integrins t 3 / l in Focal Adhesions and t 6 / 4 / Bullous Pemphigoid Antigen in a New Stable Anchoring Contact ( SAC ) of Keratinocytes : Relation to Hemidesmosomes

  2002cited by this paper
• Integrins as novel drug targets for overcoming innate drug resistance.

  2002cited by this paper
• Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.

  2002cited by this paper
• Inhibitory Role of α6β4-Associated Erbb-2 and Phosphoinositide 3-Kinase in Keratinocyte Haptotactic Migration Dependent on α3β1 Integrin

  2001cited by this paper
• Clinical significance of CD151 gene expression in non-small cell lung cancer.

  2001cited by this paper
• Deposition of Laminin 5 by Keratinocytes Regulates Integrin Adhesion and Signaling*

  2000cited by this paper
• Characterization of Integrin – Tetraspanin Adhesion Complexes : Role of Tetraspanins in Integrin Signaling

  1999cited by this paper
• Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo

  1999cited by this paper
• Characterization of Integrin–Tetraspanin Adhesion Complexes

  1999cited by this paper
• P53 Inhibits α6β4 Integrin Survival Signaling by Promoting the Caspase 3–Dependent Cleavage of Akt/PKB

  1999cited by this paper
• Loss of laminin‐5 in the epithelium–stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast

  1999cited by this paper
• Targeted Disruption of the LAMA3 Gene in Mice Reveals Abnormalities in Survival and Late Stage Differentiation of Epithelial Cells

  1999cited by this paper
• Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

  1996cited by this paper
• Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications.

  1994cited by this paper
• The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.

  1994cited by this paper
• Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes

  1990cited by this paper
• b4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis

  year unknowncited by this paper

• Cytotoxic and immunomodulatory activity of CD151-LEL-based peptides in breast cancer and THP-1 cells.

  2026cites this paper
• Cell-Instructive Biomaterials with Native-Like Biochemical Complexity.

  2025cites this paper
• Basal–epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer

  2024cites this paper
• Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets

  2024cites this paper
• Biomechanical properties of laminins and their impact on cancer progression.

  2024cites this paper
• Systematic Reversal of Drug Resistance in Cancer

  2024cites this paper
• Proteomic and Phosphoproteomic Profiling of Matrix Stiffness-Induced Stemness-Dormancy State Transition in Breast Cancer Cells.

  2024cites this paper
• Laminin I mediates resistance to lapatinib in HER2-positive brain metastatic breast cancer cells in vitro.

  2024cites this paper
• Mechanotransduction alterations in tissue-engineered tumor models for new drug interventions

  2024cites this paper
• Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer

  2024cites this paper
• TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9

  2024cites this paper
• Dysregulated Signalling Pathways Driving Anticancer Drug Resistance

  2023cites this paper
• Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition

  2023cites this paper
• Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies

  2023cites this paper
• Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC.

  2023cites this paper
• Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells

  2023cites this paper
• An overview of extracellular matrix and its remodeling in the development of cancer and metastasis with a glance at therapeutic approaches

  2023cites this paper
• Exploring the role of CD151 in the tumor immune microenvironment: Therapeutic and clinical perspectives.

  2023cites this paper
• Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models

  2023cites this paper
• FAK-SFK Signaling Integrates ECM Rigidity Sensing and Engagement of ERBB2 to Activate YAP and Promote Invasive Growth and Metastasis in Breast Cancer

  2022influential citation
• The importance of being CAFs (in cancer resistance to targeted therapies)

  2022cites this paper
• Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL)

  2022cites this paper
• Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors

  2022cites this paper
• Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response

  2022cites this paper
• The Role of Extracellular Matrix Proteins in Breast Cancer

  2022cites this paper
• Collagen XVIII promotes breast cancer through EGFR/ErbB signaling and its ablation improves the efficacy of ErbB-targeting inhibitors

  2022cites this paper
• CellectSeq: In silico discovery of antibodies targeting integral membrane proteins combining in situ selections and next-generation sequencing

  2021cites this paper
• CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer

  2021cites this paper
• The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and Metastasis

  2021influential citation
• The matrix in cancer

  2021cites this paper
• Computational‐based discovery of FAK FERM domain chemical probes that inhibit HER2‐FAK cancer signaling

  2020cites this paper
• CD151 in Respiratory Diseases

  2020cites this paper
• Key Role of CD151-integrin Complex in Lung Cancer Metastasis and Mechanisms Involved

  2020cites this paper
• CellectSeq: In Silico Discovery of Antibodies Targeting Integral Membrane Proteins Combining In Situ Selections of Phage Displayed Synthetic Antibodies and Next-Generation Sequencing

  2020cites this paper
• Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy.

  2020cites this paper
• BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways

  2020cites this paper
• Integrin Crosstalk Contributes to the Complexity of Signalling and Unpredictable Cancer Cell Fates

  2020cites this paper
• ERBB2 gene expression silencing involved in ovarian cancer cell migration and invasion through mediating MAPK1/MAPK3 signaling pathway.

  2020cites this paper
• Crosstalk between Epidermal Growth Factor Receptors (EGFR) and integrins in resistance to EGFR tyrosine kinase inhibitors (TKIs) in solid tumors.

  2020cites this paper
• Modeling chemical effects on breast cancer: the importance of the microenvironment in vitro.

  2020cites this paper
• Laminin 521 enhances self-renewal via Stat3 activation and promotes tumor progression in Colorectal Cancer.

  2020cites this paper
• Cell signaling and cancer: a mechanistic insight into drug resistance

  2019cites this paper
• Tetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cells

  2019cites this paper
• Integrin-independent support of cancer drug resistance by tetraspanin CD151

  2019cites this paper
• Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells.

  2019cites this paper
• Deletion of tetraspanin CD151 alters the Wnt oncogene-induced mammary tumorigenesis: A cell type-linked function and signaling

  2019cites this paper
• Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.

  2019cites this paper
• Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer

  2019influential citation
• Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

  2018cites this paper
• BIOPHYSICAL FEATURES OF THE EXTRACELLULAR MATRIX DIRECT BREAST CANCER METASTASIS

  2018cites this paper
• Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix

  2018cites this paper
• The opposing roles of laminin-binding integrins in cancer.

  2017influential citation
• Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy

  2017cites this paper
• 1 A Biomaterial Screening Approach to Reveal Microenvironmental Mechanisms of Drug Resistance

  2017cites this paper
• Function of the laminin-derived protein LaNt α31 in corneal epithelium

  2017cites this paper
• Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer.

  2017cites this paper
• A Biomaterial Screening Approach Reveals Microenvironmental Mechanisms of Drug Resistance

  2017cites this paper
• CD151-mediated adhesion is crucial to osteosarcoma pulmonary metastasis

  2016cites this paper
• Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells through the Activation of the MAPK/ERK Pathway

  2016cites this paper
• Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin‐332/α3 integrin axis recovery of focal adhesion kinase ubiquitination

  2016cites this paper
• The extracellular matrix in breast cancer predicts prognosis through composition, splicing, and crosslinking.

  2016cites this paper
• Pancreatic cancer stem cell markers and exosomes - the incentive push.

  2016cites this paper
• ErbB receptors and tetraspanins: Casting the net wider.

  2016cites this paper
• CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy

  2016cites this paper
• Molecular and Cellular Mechanobiology of Cancer

  2016cites this paper
• Bioengineered Platforms to Study Carcinoma Cell Response to Drug Treatment

  2016cites this paper
• Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanism.

  2016cites this paper
• Integrin β1, Osmosensing, and Chemoresistance in Mouse Ehrlich Carcinoma Cells

  2015cites this paper
• Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer

  2015influential citation
• Transmembrane 4 L Six Family Member 5 (TM4SF5)-Mediated Epithelial-Mesenchymal Transition in Liver Diseases.

  2015cites this paper
• CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasion

  2015cites this paper
• Targeting HER2 for the treatment of breast cancer.

  2015cites this paper
• Emerging links of CD151 and integrins to tumorigenesis and EMT induction in ovarian cancer

  2015cites this paper
• CD151—A Striking Marker for Cancer Therapy

  2015cites this paper
• A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy

  2015cites this paper
• GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1

  2015cites this paper
• Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer.

  2015cites this paper
• Insulin-Like Growth Factor-1 Receptor Signaling Increases the Invasive Potential of Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer Cells via Src-Focal Adhesion Kinase and Forkhead Box Protein M1

  2015cites this paper
• CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion

  2015influential citation
• Lewis y enhances CAM-DR in ovarian cancer cells by activating the FAK signaling pathway and upregulating Bcl-2/Bcl-XL expression.

  2015cites this paper
• CD151 represses mammary gland development by maintaining the niches of progenitor cells

  2014cites this paper
• Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns

  2014cites this paper
• Correlations between Transmembrane 4 L6 Family Member 5 (TM4SF5), CD151, and CD63 in Liver Fibrotic Phenotypes and Hepatic Migration and Invasive Capacities

  2014cites this paper
• Integrins: players in cancer progression and targets in cancer therapy

  2014cites this paper
• CD 151-α 3 β 1 Integrin Complexes Suppress Ovarian Tumor Growth by Repressing Slug-Mediated EMT and Canonical Wnt Signaling

  2014cites this paper
• Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening.

  2014cites this paper
• Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies

  2014cites this paper
• CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling

  2014cites this paper
• Integrin α3β1–CD151 complex regulates dimerization of ErbB2 via RhoA

  2014cites this paper
• CD151 in cancer progression and metastasis: a complex scenario

  2014cites this paper
• Correction: Correlations between Transmembrane 4 L6 Family Member 5 (TM4SF5), CD151, and CD63 in Liver Fibrotic Phenotypes and Hepatic Migration and Invasive Capacities

  2014cites this paper
• Molecular and Cellular Pathobiology Integrin-Free Tetraspanin CD 151 Can Inhibit Tumor Cell Motility uponClustering and Is aClinical Indicator of Prostate Cancer Progression

  2013cites this paper
• The CD9/CD81 Tetraspanin Complex and Tetraspanin CD151 Regulate α3β1 Integrin-Dependent Tumor Cell Behaviors by Overlapping but Distinct Mechanisms

  2013cites this paper
• Integrin Signaling as a Cancer Drug Target

  2013cites this paper
• The small molecule genkwanine M induces single mode, mesenchymal tumor cell motility.

  2013cites this paper
• ErbB/integrin signaling interactions in regulation of myocardial cell-cell and cell-matrix interactions.

  2013cites this paper
• Tetraspanins

  2013cites this paper
• Tetraspanin proteins promote multiple cancer stages

  2013cites this paper
• The Role of Tetraspanins in Cell Migration and Intercellular Adhesion

  2013cites this paper
• Normal physiology relies on the organization of transmembrane proteins by molecular scaffolds, such as tetraspanins. Oncogenesis frequently involves changes in their organization or expression. The tetraspanin CD151 is thought to contribute to cancer progression through direct interaction with the l

  2013cites this paper